Award
NIH Reporter #11249187
Detection of PD-1 inhibitory signaling and its molecular relays in T cells: Implications for cancer immunotherapy
Recipient
BETH ISRAEL DEACONESS MEDICAL CENTER
Award Amount
$711,511.00
Ceiling
$711,511.00
Awarded
January 22, 2026
Identifier
11249187
Research project awarded to study PD-1 signaling in T cells for cancer immunotherapy, funded by the National Cancer Institute.
Description
The project focuses on studying PD-1 signaling in T cells and its implications for cancer immunotherapy. The award is from the National Cancer Institute (NCI), part of NIH. The project involves multiple investigators and aims to identify molecular and biochemical properties of T cells in cancer and healthy individuals. The project includes single-cell immunoprofiling and analysis of patient biopsies.